Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

URGNURGN
Showing 8 of 26 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in UROGEN PHARMA LTD

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 128,370 shares of URGN (UROGEN PHARMA LTD), worth $4.7M as of 2026-Q2. The position was increased (+45.1% shares). URGN represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$4.7M

Current Shares

128,370

Total Value Change

+$3.6M

Total Shares Change

+37,877

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
128,370
+45.1%
$4.7M0.0%$36.80
36
2026-Q1
Decreased
88,466
-2.8%
$1.6M0.0%$18.82
0
2025-Q4
Decreased
90,989
-0.1%
$2.1M0.0%$23.17
0
2025-Q3
Decreased
91,059
-2.0%
$1.8M0.0%$19.14
0
2025-Q2
Decreased
92,898
-0.7%
$1.3M0.0%$13.49
0
2025-Q1
Increased
93,547
+0.0%
$1M0.0%$11.20
25
2024-Q4
Increased
93,517
+3.3%
$995,9560.0%$10.52
26
2024-Q3
Increased
90,493
+9.1%
$1.1M0.0%$12.90
28

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used